Cinctive Capital Management LP Has $8.94 Million Stock Holdings in Sanofi (NASDAQ:SNY)

Cinctive Capital Management LP boosted its stake in shares of Sanofi (NASDAQ:SNY) by 106.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 155,109 shares of the company’s stock after buying an additional 80,033 shares during the period. Cinctive Capital Management LP’s holdings in Sanofi were worth $8,939,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Northwest Investment Counselors LLC acquired a new stake in shares of Sanofi during the third quarter worth $29,000. POM Investment Strategies LLC acquired a new stake in shares of Sanofi in the 2nd quarter valued at about $25,000. Concord Wealth Partners lifted its holdings in shares of Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares in the last quarter. Arrow Financial Corp acquired a new position in shares of Sanofi during the second quarter worth about $35,000. Finally, Fortitude Family Office LLC grew its holdings in shares of Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares in the last quarter. Institutional investors own 10.04% of the company’s stock.

Analyst Upgrades and Downgrades

SNY has been the topic of several research reports. Citigroup upgraded Sanofi to a “strong-buy” rating in a research note on Tuesday, September 17th. StockNews.com cut shares of Sanofi from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Stock Down 0.5 %

NASDAQ:SNY opened at $48.49 on Monday. The firm has a market capitalization of $123.06 billion, a price-to-earnings ratio of 24.74, a price-to-earnings-growth ratio of 1.23 and a beta of 0.61. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97. The stock’s 50 day moving average price is $52.80 and its two-hundred day moving average price is $52.15.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $1.35. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The firm had revenue of $13.44 billion for the quarter, compared to analyst estimates of $16.59 billion. During the same period in the prior year, the firm posted $2.55 earnings per share. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. Equities research analysts expect that Sanofi will post 4.28 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.